# Amandeep Salhotra, M.D. – FDA Inspection, Dec 4, 2025

Source: https://www.keypedia.com/records/fda_inspections/amandeep-salhotra-md/586d0b0c-778a-451e-9e7f-3af33e7e75d7
Source feed: FDA_Inspections

> FDA inspection 1294054 of Amandeep Salhotra, M.D., December 04, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1294054
- Company Name: Amandeep Salhotra, M.D.
- Inspection Date: 2025-12-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1238448 - 2024-05-02](https://www.keypedia.com/records/fda_inspections/amandeep-salhotra-md/e9707617-0fde-4e8b-a5cf-2ab3aafba0a1)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)

Company: https://www.keypedia.com/companies/amandeep-salhotra-md/2548bc0b-3691-423f-b027-a2bbbd3e0cdb

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b